Literature DB >> 4009289

Determination of clinical efficacy: nuclear medicine as applied to lung scanning.

E L Saenger, C R Buncher, B L Specker, R A McDevitt.   

Abstract

This paper describes a Society of Nuclear Medicine sponsored study of 2,023 patients which compares two methods, logistic regression (LR) and entropy minimax pattern detection (EMPD), to evaluate efficacy. Lung scans, used in determining or excluding a diagnosis of pulmonary embolism (PE), were utilized to create the data set. The LR analysis, presented here, shows that lung scan findings have significant influence on the referring physician's diagnostic thinking. Models were developed for the probability of a signout diagnosis of PE, and equal patient groups tested the validity of these regression equations. Individual models developed on each patient group yielded similar results. This analysis shows that the lung scan results affect the therapeutic management of the patients in a beneficial direction. A comparison of the sensitivity, specificity, and predictive values of EMPD and LR was done. EMPD predicts a signout diagnosis on only 41% of cases before lung scan and 71% after lung scan; LR provides a prediction of the signout diagnosis on 100% of cases. An advantage of EMPD is that it does not require prior probability estimates. However, LR uses this estimate, thus incorporating intuitive knowledge not evaluated by EMPD.

Entities:  

Mesh:

Year:  1985        PMID: 4009289

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  2 in total

1.  Diagnostic modalities for detection of pulmonary embolism in clinical routine: a European survey.

Authors:  H Köhn; D Köhler
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Suspected pulmonary embolism and lung scan interpretation: trial of a Bayesian reporting method.

Authors:  D M Becker; J T Philbrick; F W Schoonover; C D Teates
Journal:  J Gen Intern Med       Date:  1990 Jul-Aug       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.